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Genetically modified mice provide a number of models for studying cardiac channelopathies
related to cardiac Na+ channel (SCN5A) abnormalities. We review key pathophysiologi-
cal features in these murine models that may underlie clinical features observed in sinus
node dysfunction and progressive cardiac conduction disease, thereby providing insights
into their pathophysiological mechanisms. We describe loss of Na+ channel function and
fibrotic changes associated with both loss and gain-of-function Na+ channel mutations.
Recent reports further relate the progressive fibrotic changes to upregulation of TGF-β1
production and the transcription factors, Atf3, a stress-inducible gene, and Egr1, to the
presence of heterozygous Scn5a gene deletion. Both changes are thus directly implicated
in the clinically observed disruptions in sino-atrial node pacemaker function, and sino-atrial
and ventricular conduction, and their progression with age. Murine systems with genetic
modifications in Scn5a thus prove a useful tool to address questions concerning roles of
genetic and environmental modifiers on human SCN5A disease phenotypes.
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INTRODUCTION
The SCN5A gene directs synthesis of cardiac-type, voltage-
dependent, Na+ channels (Nav1.5), abundant in the heart. The
simultaneous and transient openings of large numbers of voltage-
gated Na+ channels mediate the rapid inward current responsible
for the rising phase of the cardiac action potential (AP). This is
fundamental to initiation, propagation, and maintenance of the
normal cardiac rhythm that ensures synchronized atrial and ven-
tricular contraction and therefore the normal heartbeat. SCN5A
mutations are associated with cardiac arrhythmic syndromes rang-
ing from chronic bradyarrhythmias to acute life-threatening tach-
yarrhythmias. These include the congenital long QT syndrome
subtype 3 (LQT3; Wang et al., 1995), Brugada syndrome (BrS;
Chen et al., 1998; Brugada et al., 2000), isolated cardiac conduction
disease (CCD; Schott et al., 1999), sinus node dysfunction (SND;
Benson et al., 2003), and sudden infant death syndrome (SIDS;
Otagiri et al., 2008). Over the past decade, mouse models with
genetic modifications in SCN5A have provided invaluable insights
into these cardiac disorders. This review summarizes recent stud-
ies on Nav1.5 disorders and their bearing on cardiac conduction
properties.
THE ROLE OF VOLTAGE-GATED NA+ CHANNELS IN CARDIAC
PACEMAKER FUNCTION
The last two decades have seen significant progress in our under-
standing of the molecular structure of voltage-gated Na+ channels
(reviews Goldin, 2001, 2002; Catterall et al., 2003). These chan-
nels comprise pore-forming α-subunits, with molecular weights
of ∼260 kDa, and associated auxiliary β-subunits with molecular
weights∼36 kDa (Goldin, 2002; Catterall et al., 2003). Expression
of the α-subunit alone is sufficient for functional Na+ current
expression, but the presence or absence of β-subunits modifies
the kinetics and voltage-dependence of channel gating. The α-
subunits are organized into four homologous domains (I–IV).
Each contains six transmembrane α-helices (S1–S6) and includes
an additional pore loop located between the S5 and S6 helices. The
various α-subunit isoforms are differentially expressed in differ-
ent tissues and have distinct pharmacological properties (Goldin,
2002; Catterall et al., 2003).
Recent investigations also demonstrate that in addition to
Nav1.5, different cardiac tissues co-express a range of different α-
subunit isoforms. These include several neuronal, Nav1.1, Nav1.3,
and Nav1.6, isoforms primarily expressed in brain (Maier et al.,
2002; Lei et al., 2004). This pattern is exemplified by the SA node,
which shows a complex co-expression of multiple Nav isoforms.
It contains both Nav1.5 and Nav1.1 with Nav1.5 absent in the cen-
tral nodal cells (Lei et al., 2004). Nav1.3 is also present in mouse
(Maier et al., 2002) but not rabbit or rat SA node (Baruscotti et al.,
1997; Maier et al., 2002). More recent, competitive RT-PCR and
immunohistological, studies have demonstrated Nav1.1, Nav1.2,
and Nav1.5 expression in canine SA and atrioventricular (AV)
nodes (Haufe et al., 2005).
Recent studies have also clarified the functional roles of these
distinct cardiac and neuronal-type Na+ channels in the SA node.
First, it is likely that the tetrodotoxin (TTX)-sensitive neuronal
(Nav1.1) Na+ current is involved in pacemaker function in the
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SA node. Nanomolar TTX concentrations known to only inhibit
neuronal Na+ current slowed down pacemaker rates of intact
mouse hearts by ∼65% (Maier et al., 2002) isolated SA nodes
by ∼22% and isolated SA nodal pacemaker cells by ∼15% (Lei
et al., 2004). Furthermore, studies using the AP clamp technique
demonstrated that the neuronal Na+ current could be activated
within the voltage ranges of the pacemaker potential (Lei et al.,
2004).
In contrast, the TTX-resistant cardiac (Nav1.5) Na+ current is
likely to be important in AP propagation and conduction through
the SA node. Thus, measurements of SA node conduction times
demonstrated that block of both TTX-sensitive and TTX-resistant
Na+ current by µM TTX slowed or even blocked AP conduction
through the SA node periphery, from the leading pacemaker site
in the center of the SA node to the surrounding atrial muscle.
However, block of the TTX-sensitive Na+ current alone by 10 or
100 nM TTX did not produce such effects (Lei et al., 2004).
Together these findings implicate both neuronal (Nav1.1) and
cardiac (Nav1.5) Na+ channels in pacemaker activities as well as
AP conduction through the SA node and from the SA node to
surrounding atrial muscle. Their demonstration of physiological
roles for Nav1.5 in SA node function underpins our understand-
ing of the SND attributed to genetic defects in Nav1.5 channel, as
discussed in the sections below.
SCN5AMUTATIONS AND HUMAN CARDIAC CONDUCTION
DISEASES
SINUS NODE DYSFUNCTION
Sinus node dysfunction is associated with abnormal impulse for-
mation and propagation in the SA node. It presents clinically
as sinus bradycardia, sinus pause or arrest, atrial chronotropic
incompetence, and SA node exit block (Freedman, 2001). It affects
∼1 in 600 cardiac patients older than 65 years and is respon-
sible for ∼50% of the million permanent pacemaker implants
per year worldwide (de Marneffe et al., 1993; Dobrzynski et al.,
2007). Thus far, 13 human Nav1.5 (hNav1.5) mutants have been
associated with familial SND (reviews: Lei et al., 2007, 2008).
In expressed heterologous systems, these fall into three groups
respectively generating peak Na+ currents that were compara-
ble to those observed for wild-type hNav1.5 (e.g., L212P, P1298L,
DelF1617, and R1632H), significantly reduced but nevertheless
detectable (e.g., E161K, T220I, and D1275N) or undetectable
(e.g., T187I, R878C, G1408R, and the truncated variants W1421X,
K1578fs/52, and R1623X; Gui et al., 2010). Their comparisons with
the corresponding clinical outcomes suggest that SCN5A haploin-
sufficiency markedly reducing Na+ current can result in SND.
However, disease phenotypes can be accompanied by other cardiac
excitation disorders: further factors besides Na+ current reduction
and aging may also contribute to development of SND phenotypes
(Leoni et al., 2010).
PROGRESSIVE CARDIAC CONDUCTION DISEASE
Progressive cardiac conduction disease (PCCD), also known as
Lev–Lenegre disease (Schott et al., 1999), presents as a pro-
gressive prolongation of electrocardiographic cardiac conduction
parameters. PCCD is most commonly seen in the elderly, and
has been attributed to senile degeneration of the conduction sys-
tem. Hereditary PCCD has been attributed to loss-of-function
SCN5A mutations that reduce Na+ current by decreasing sar-
colemmal expression of channel proteins, causing an expression
of non-functional channels, or altering channel gating proper-
ties through delayed activation, earlier inactivation, enhanced slow
inactivation, or slowed recovery from inactivation (Tan et al., 2001;
Probst et al., 2003; Zimmer and Surber, 2008). Moreover, a sin-
gle SCN5A mutation may cause either an isolated PCCD or an
overlap syndrome with PCCD co-existing with BrS (Zimmer and
Surber, 2008). This suggests that in addition to reductions in Na+
current sufficient to slow conduction in PCCD or BrS, other fac-
tors contribute to the development of the typical right-precordial
ST segment elevation in BrS. Further reports describe overlaps
between gain- and loss-of-function phenotypes associated with a
single C-terminal 1795insD gene mutation yielding ECG features
of bradycardia, conduction disease, LQT3, and BrS (Bezzina et al.,
1999).
MOUSE MODELS OF CARDIAC CONDUCTION DISEASES
ASSOCIATED WITH SCN5AMUTATIONS
A mouse model containing a disrupted Nav1.5 gene, Scn5a, was
developed a decade ago (Papadatos et al., 2002). Homozygotes
show intrauterine lethality with severe defects in ventricular mor-
phogenesis. Scn5a+/− heterozygotes show normal survival but a
number of electrophysiological defects including impaired atri-
oventricular conduction, delayed intramyocardial conduction,
increased ventricular refractoriness, and ventricular tachycar-
dia with characteristics of re-entrant excitation. Single whole-
cell patch clamp studies of isolated adult Scn5a+/− ventricular
myocytes demonstrated a ∼50% reduction in Na+ conductance.
Such mice thus provide a unique and valuable model system for
studying physiological effects of cardiac Na+ channelopathies.
LOSS OF Nav1.5 CHANNEL FUNCTION AND SINUS NODE DYSFUNCTION
Long-term telemetric ECG recordings demonstrated that
Scn5a+/− mice retain physiological circadian variations in heart
rates but replicated the depressed mean rates and persistent SA
block observed in patients with SND (Asseman et al., 1983).
Isolated hearts similarly showed a sinus bradycardia, slowed SA
conduction, and sino-atrial exit block. Isolated Scn5a+/− SA node
and atrial preparations (Figure 1) showed slowed SA conduc-
tion and frequent SA conduction block. Patch clamp analyses of
Scn5a+/− SA node cells demonstrated similar steady-state acti-
vation and inactivation properties but reduced maximum Na+
currents (∼30%) compared to WT (Lei et al., 2005). These studies
together implicate the Scn5a Na+ channel in both pacemaker and
conduction functions of the mouse SA node, and in the clinical
consequences of SND.
LOSS OF Nav1.5 CHANNEL FUNCTION AND PROGRESSIVE CARDIAC
CONDUCTION DISEASE
Scn5a+/− mice have been further investigated for potential patho-
physiological mechanisms involved in the progressive evolution
of SCN5A-related PCCD (Royer et al., 2005; van Veen et al.,
2005). Atrial, atrioventricular, and ventricular conduction veloc-
ities were all prolonged to extents that increased with age. This
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FIGURE 1 | SAN pacemaking and conduction inWT and Scn5a+/−
mice. (A) Example of SAN preparation used for electrical mapping.
Scale bar, 200µm. (B,C) Activation sequence in SAN of WT and
Scn5a+/−. (D,E) Action potentials recorded from sites near the center
of the SAN in (A,B) from WT (left) and Scn5a+/− (right) SAN
preparations. (F,G) SAN conduction in WT and Scn5a+/− preparations.
Extracellular potentials from sites a [leading pacemaker site in the
center of the SAN; see (B,C)] and c (atrial muscle, AM) shown.
Vertical dashed lines indicate the time of initiation of the AP at the
leading pacemaker site (left) and the arrival of the AP in atrial muscle
(right). (H) Simultaneous SAN and atrial muscle recordings showing
sino-atrial conduction block in Scn5a+/− SAN, never observed in WT.
SEP, septum; SVC, superior vena cava; IVC, inferior vena cava; CT,
crista terminalis; and RA, right atrial appendage.
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FIGURE 2 | Characterization of remodeling of extracellular matrix in
the SAN. (A) Picosirus red collagen staining in SAN section from each of
four groups of mice. (B) Vimentin immunostaining for fibroblasts in SAN
tissue sections. (C) Collage quantification: area of picosirus red-stained
tissue expressed as a percentage of the field of view. (D) Fibroblast
quantification with area of vimentin staining expressed as a percentage of
the field of view. Y, young mice; O, old mice. Two-way ANOVA: P<0.05,
Scn5a+/− vs. WT mice; P<0.001, young vs. old mice.
feature was confirmed by activation mapping studies performed
in Langendorff-perfused hearts. In young Scn5a+/− mice, con-
duction velocity was only affected in the right ventricle. In old
mice, the right ventricular conduction defect worsened and was
also associated with conduction velocity defects in the left ventri-
cle. This age-dependent deterioration of ventricular conduction
was associated with the occurrence of fibrosis in the ventricular
myocardium (Jeevaratnam et al., 2011).
GAIN OF Nav1.5 FUNCTION AND SINUS NODE DYSFUNCTION
SA node function in mice heterozygous for a knock-in, gain-of-
function KPQ-deletion (Scn5a+/∆) also appears to recapitulate
major features of SND reported in LQT3 patients, suggesting phe-
notypic overlaps with loss-of-function Na+ channel mutations.
Abrupt accelerations in heart rate or premature beats thus caused
AP lengthening, early after depolarizations, and triggered arrhyth-
mias (Nuyens et al., 2001). Electrophysiological characterizations
of SA node function in intact Scn5a+/∆ mice and in vitro sino-
atrial preparations were compared with features of cellular SA
node and two-dimensional tissue models exploring consequences
of Scn5a+/∆ mutations. Whilst showing prolonged electrocardio-
graphic QT and QTc intervals expected for LQT3, Scn5a+/∆ mice
showed frequent episodes of sinus bradycardia, sinus pause/arrest,
and increased sinus node recovery times, suggesting compromised
pacemaker activity, as well as depressed intra-atrial, atrioventric-
ular node, and intraventricular conduction. Isolated SA prepara-
tions correspondingly showed lower mean intrinsic heart rates and
slower conduction both within the SA node and from SA node to
surrounding atrium. Modeling studies reconstructed such find-
ings through a combination of augmented tail and reduced peak
Na+ currents attributable to downregulation of a Na+ channel that
itself shows increased tail currents as a result of a gain-of-function
mutation (Wu et al., 2012).
Veldkamp et al. (2003) also studied the effects of the 1795insD
Na+ channel mutation on SA pacemaker function using experi-
mental models in HEK-293 cells and computer simulation. They
demonstrated late Na+ currents from the 1795insD channels
whose magnitude varied between 0.8± 0.2 and 1.9± 0.8% of peak
Na+ current. AP clamp experiments confirmed an existence of
1795insD channel activity during SA node pacemaker function.
Computational models for the SA node AP then incorporated late
Na+ current and the negative shift in voltage-dependence of inac-
tivation. Such negative shifts decreased the sinus rate by decreasing
the diastolic depolarization rate, whereas the presence of late Na+
current decreased the sinus rate by AP prolongation, despite a con-
comitant increase in diastolic depolarization rate. This suggested
that Na+ channel mutations displaying a late Na+ current or a
negative shift in inactivation may account for the bradycardia seen
in LQT3 patients, whereas SA node pauses or arrest may result
from failure of SA node cells to repolarize under conditions of
extra net inward current (Veldkamp et al., 2003).
GAIN OF Nav1.5 FUNCTION AND CONDUCTION FAILURE
The overlap patterns indicated above involving gain- and loss-of-
function phenotypes can also involve atrial and ventricular con-
duction. 1795insD hearts combine a preferential right ventricular
conduction slowing accompanied by reduced peak sodium current
densities, and AP upstroke velocities with AP prolongation, slowed
Na+ current decays but normal activation and inactivation char-
acteristics, and increased persistent inward currents compared to
WT (Remme et al., 2006). Increased atrial arrhythmic tendencies
in aging gain-of-function Scn5a+/∆ are accompanied by reduc-
tions in conduction velocity that could result from downregulation
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of Nav1.5 in contrast to its increased expression in WT hearts
(Guzadhur et al., 2010).
RECENT NEW INSIGHTS INTO THE MOLECULAR BASIS OF
SCN5AMUTATIONS AND HUMAN CARDIAC CONDUCTION
DISEASES
Recent studies have explored for possible relationships between
the pathogenesis of SND, aging processes, and Scn5a-disruption,
as well as their possible interactions in the Scn5a+/−mouse model
(Hao et al., 2011). These associated both electrical remodeling and
tissue degeneration, detected as a TGF-β1-mediated fibrosis, with
altered pacemaker and conduction function in SND. Such changes
occurred with both Scn5a-disruption and aging. A combination
of both factors produced the most severe phenotype. Thus, ex
vivo SA node preparations isolated from their autonomic inputs
then showed increased cycle lengths and sino-atrial conduction
times. These changes accompanied alterations in the extent of
fibrosis assessed by collagen and fibroblast levels, and ion channel
and regulatory gene transcriptional remodeling. Aging and Scn5a-
disruption correspondingly resulted in interacting up-regulatory
effects on levels of the key modulator of fibrosis, TGF-β1, and the
fibroblast marker, vimentin. The latter changes were also great-
est in the old Scn5a+/− hearts (Figure 2). Altered expression of
TGF-β1 and vimentin transcripts are associated with increased
collagen and fibroblast abundance indicating an occurrence of
interstitial fibrosis. The fibrosis could potentially slow conduction
both within the SA node and from the SA node to the surround-
ing atrium. Its occurrence parallels previous reports associating
the Scn5a+/− condition and similar, ventricular, fibrotic changes
(Royer et al., 2005; van Veen et al., 2005) as well as associating
age-dependent SND and fibrosis (Benditt et al., 1990) although
such features were not observed in all studies (Alings et al., 1990;
Alings and Bouman, 1993). In implicating Nav1.5 deficiency in
such changes these findings additionally suggest novel regulatory
roles for Nav1.5 in cellular biological processes extending beyond
its electrical function.
The above findings add to studies that similarly showed that
heterozygous Scn5a inactivation in mouse produces ventricular
rearrangements and fibrosis with aging (Royer et al., 2005; van
Veen et al., 2005; Leoni et al., 2010). They also demonstrated
aging resulted in an upregulation of two transcription factors,
Atf3, a stress-inducible gene, and Egr1, an early growth response
gene, particularly in Scn5a+/− mice (Royer et al., 2005; van Veen
et al., 2005). Furthermore, the variable Nav1.5 protein expression
from the WT allele correlates with the extent of PCCD in the
Scn5a+/− mouse model (Leoni et al., 2010). This study (Leoni
et al., 2010) divided 10-week-old Scn5a+/− mice into two electro-
cardiographic subgroups showing either severe or mild ventricular
conduction defects. These phenotypic differences persisted with
aging. At 10 weeks, the Na+ channel blocker ajmaline produced
similar prolongations of QRS intervals in both groups of Scn5a+/−
mice. However, the effect of ajmaline was greater in the severely
affected subgroup in old mice (>53 weeks). Ventricular tachycar-
dia developed in 5- to 10-week-old severely but not mildly affected
Scn5a+/− mice. Such findings therefore matched clinical obser-
vations in patients with SCN5A loss-of-function mutations with
either severe or mild conduction defects. The severely but not
mildly affected old Scn5a+/− mice also showed extensive cardiac
fibrosis. Finally, the severely affected Scn5a+/− mice had similar
Nav1.5 mRNA but lower Nav1.5 protein expression, moderately
smaller Na+ currents, and reduced AP upstroke velocities than the
mildly affected Scn5a+/− mice.
CONCLUSION
Mice have become powerful tools for clarifying the pathophys-
iological consequences of SCN5A mutations in SCN5A-related
cardiac disorders. Mice harboring SCN5A mutations related to
PCCD and SND convincingly recapitulate the clinical pheno-
types of PCCD and SND in patients, and provide insight into
the mechanisms of SCN5A deficiency-associated cardiac conduc-
tion diseases. They should constitute useful tools for future studies
addressing as yet unanswered questions, such as the role of genetic
and environmental modifiers on SCN5A disease phenotypes.
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